chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bell's Palsy, onset 10/13/21, treatment with prednisone and Valtrex, currently unresolved
Mild Chest pain began to occur roughly a week after vaccination. Two weeks after vaccination it had processed to severe bouts of pain accompanied with dizziness and fatigue. After about a week of severe pain, the pain began to taper off and seemed to move from my chest more into my armpit and arm. A swollen and painful lymph node occurred in my left armpit roughly 2 weeks after severe pain had started. The lymph node is currently still swollen but it's getting mildly better. Chest pain is not entirely gone but it's also getting better slowly.
Hot flashes both occasionally; Fourth week of having nausea; Headaches; This spontaneous case was reported by a health care professional and describes the occurrence of HOT FLUSH (Hot flashes both occasionally), NAUSEA (Fourth week of having nausea) and HEADACHE (Headaches) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 010A21A) for COVID-19 immunisation.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced HOT FLUSH (Hot flashes both occasionally), NAUSEA (Fourth week of having nausea) and HEADACHE (Headaches). The patient was treated with OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) at a dose of 1 dosage form and LANSOPRAZOLE (PREVACID) at a dose of 1 dosage form. At the time of the report, HOT FLUSH (Hot flashes both occasionally), NAUSEA (Fourth week of having nausea) and HEADACHE (Headaches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information  provided. Action taken was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-jun-2021 , Contains no new information
She was a little tired (fatigue) after the shot; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (She was a little tired (fatigue) after the shot) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TREPROSTINIL SODIUM (REMODULIN) for Pulmonary arterial hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension and Seasonal allergy (seasonal allergy were bad at the time of report.).   On 21-May-2021, the patient started TREPROSTINIL SODIUM (REMODULIN) (Intravenous) .042 microgram/kilogram. On 21-May-2021, TREPROSTINIL SODIUM (REMODULIN) (Intravenous) dosage was changed to concentration 1.0 mg/ml. On 06-Jun-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jun-2022, the patient experienced FATIGUE (She was a little tired (fatigue) after the shot). At the time of the report, FATIGUE (She was a little tired (fatigue) after the shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, Weight decreased: 97.4 97.4 lbs and. In June 2022, Weight decreased 97 97 lbs.         The weight of the patient in May-2022 was reported as 96.6 lbs.  Concomitant medications were not reported.  The patient had took second booster dose.  The patient began therapy with Remodulin (treprostinil sodium, concentration 1.0 mg/ml) on 21-May-2021 for primary pulmonary arterial hypertension. On an unreported date, the patient experienced event of weight loss (weight decreased). Action taken with IV Remodulin was not reported for the event of weight decreased. At the time of reporting, the outcome of weight decreased was unknown. Patient reported that a new central line was placed, and sutures were little irritated (suture related complication). At the time of reporting, the outcome of suture related complication was unknown. The reporter did not provide causality for the event of suture related complication. It was reported that patient had the line replaced in April. Patient had an embedded suture that was irritating the site, which was red and sore (injection site irritation, injection site erythema, injection site pain and suture related complication, previously reported). The physician advised that there were no infections. Action taken with IV Remodulin was not reported for the events of injection site irritation, injection site erythema, injection site pain, seasonal allergy, and fatigue. At the time of reporting, the outcome of injection site irritation, injection site erythema, injection site pain, seasonal allergy and fatigue was unknown.  Treatment information was not reported.
First injection on 12/19/2020 followed by arthralgias. Second dose on 1/7/2021, starting around 11 AM on 1/9/2021, significant myalgias and arthralgias which evolved into involuntary choreoathetoid movements requiring hospitalization. I presented to the ED around 15:30 on 1/9/2021 with subsequent admission and work up as listed below.
FEVER A FEW HOURS AFTER INJECTIONS. MOTHER STATES THAT IT WAS 101.9.
Initially noted on May 22nd  moderate hives on both lower legs. After 7 days developed into a petechial rash approximately 15 x 6 cm left calf and 18 x 8 cm on the right. Rash slowly resolved over the following 7-10 days. Not painful or very pruritic but patient does have neuropathy.
Patient called today, received the vaccine at a pharmacy, at 11 am.  At 10pm now feeling like he cannot swallow, pale, chest pain, irritated throat. Was dispositioned by On call Provider Dr to seen medical care in the ED.
right arm pain; Difficult breathing; fast heartbeat; weakness; tingling; numbness off my upper body and face jaw locking; hands locking stomach painful cramps; numbness off my upper body and face jaw locking, hands locking stomach painful cramps; vomiting; high blood pressure elevated to 190/110; dry mouth follow by thrust develop a mild cough and right arm pain; dry mouth follow by thrust develop a mild cough and right arm pain; This is a spontaneous report from a contactable Consumer. A 42-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0169), dose 1 via an unspecified route of administration, administered in Arm Left on 07May2021 15:00 (at the age of 42-years-old) as a single dose for covid-19 immunization. Medical history included anaphylactic reaction from 07May2021 to an unknown date and high blood pressure. Concomitant medication(s) in two weeks included hydrochlorothiazide; losartan; iron (FERROUS [IRON]). The patient was not pregnant at the time of vaccination. It was unknown, the patient had any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown the patient had been tested for COVID-19. On 07May2021 15:15, the patient experienced "difficult breathing fast heartbeat weakness tingling follow by numbness off my upper body and face jaw locking, hands locking stomach painful cramps follow by vomiting high blood pressure elevated to 190/110, dry mouth follow by thrust develop a mild cough and right arm pain". The adverse event resulted in patient to visit emergency room/department or urgent care. The patient was treated with Paramedics help, oxygen given. The patient underwent lab tests and procedures which included blood pressure measurement: 190/110. Outcome of the event was recovering.  No follow-up attempts are needed. No further information is expected.
pt rcvd vax; devel high pitched screaming, low grade fever, inject site rxn w/ swelling and tenderness.  three pt exp adverse events from this site post rcv vax.
Pt rec'd vaccine approx 4pm at MD office. Reports that night became ill, chills, vomiting, fever, lethargic weak, sx. lasted 48 hours then resolved on their own.
Patient came in for covid booster, received 2 doses of Moderna, pt report received Pfizer, did not have vaccine card to confirm, wife also presented for covid booster, reported Pfizer was given for the first 2 doses, had card to confirm. It was discovered after administering Pfizer booster the patient received Moderna.
Patient developed bruising at injection site after withdrawal of needle, after 15 minutes had a small hematoma that improved with direct pressure for 15 minutes, and continued to apply pressure several times over the next 12 hours.
Body ache; Fatigue; Soreness at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 01Apr2021 at 12:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 16:00, the patient experienced fatigue, body ache and soreness at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The patient did not receive any treatment for the event. The clinical outcome of the event fatigue, body ache and soreness at injection site were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
I have had sores inside and outside of my mouth after receiving 1st dose. Continued and worsened after 2nd dose. Also had a very bad depression session 10 days after 2nd dose.
Pfizer was reconstituted with sterile water instead of normal saline and administered.  The patient has not reported any adverse effects
Vaccine kept in freezer in 3 weeks vs 2 weeks as recommended. Spoke to patient today to come in to have dose repeated per guidelines. Patient stated after she received the dose, the following day she had SOB. She had to go home from work and get her inhaler. Patient was very close to going to the ER. Also the following day, her right arm and axillary were swollen and had pain. Took Ibuprofen. Today she is 70% better.
Developed lateral left breast pain the day after the vaccine that has persisted. Pain worse with palpation and pressure. No redness or breast discharge to suggest mastitis. No lymphadenopathy. No masses palpated.
Started with watery and glassy eyes, progressed to a low grade fever, change in temperment, fever increased, headache, loss of appetite, fluid intake challenging, fever still incresed to 102.3, slight coug and runny nose, gave tylenol and motrin for fever.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 32-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "known allergies: CT contrast dye" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE; SYNTHROID; VITAMIN D3; VITAMIN B12 [CYANOCOBALAMIN]; NUVARING. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included PAXLOVID. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Syncope/fainting 14 hours post vaccine. Fever began around 9 hours post vaccine and was 4 degrees above my normal temperature. Extreme chills and shaking, became dizzy and fainted, out for about a minute . Laid on ground for a while, returned to bed and took Advil for fever
Right thigh with 3 cm edematous area, no erythema, no streaks given Rx for Keflex and ibuprofen susp. for fever/pain. Pt afebrile at home and in clinic.
TINNITUS STOPPED( HAD COMPLETELY DISAPPEARED FOR MORE THAN 04 DAYS); TINNITUS RECURRENCE (GRADUALLY RETURNING FROM PAST WEEK); This spontaneous report received from a patient via a company representative . The patient's height, and weight were not reported. The patient's concurrent conditions included neurological disabilities, and tinnitus. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. Concomitant medications included vilazodone hydrochloride for neurological disabilities.  On an unspecified date, the subject experienced tinnitus stopped ( had completely disappeared for more than 04 days), and tinnitus recurrence (gradually returning from past week). The action taken with covid-19 vaccine ad26.cov2.s was not reported. The patient had not recovered from tinnitus stopped( had completely disappeared for more than 04 days), and the outcome of tinnitus recurrence (gradually returning from past week) was not reported. This report was non-serious.
My left leg significantly began buzzing for about 6- 7 minutes, then there was some uncomfortable aching pain in that left knee and leg. Have never had this before as a symptom. My heart was racing for 3-5 minutes.  Once or twice next 2 days, the leg buzzed for a few minutes and hurt up and down the leg.
swollen face and hives; swollen face and hives; This is a spontaneous report from a contactable consumer from a sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 12Feb2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On 13Feb2021, the patient experienced swollen face and hives (non-serious).  The clinical outcome of the events was unknown.  The batch/lot numbers for the vaccine, bnt162b2, were not provided and will be requested during follow up.
Child presented to the office today 06/13/2018 with a chickenpox rash over entire body. TYLENOL given at home by parent since child was very irritable prior to coming to the office. Advised to follow up in the office should the childs temp elevate greater than 100.4. Advised parents to contact office immediately.
Varicella vaccine breakthrough. Diagnosed with varicella on 1-19-09.
extremely itchy, swelling at the injection site; my skin around the injection site was shiny; extremely itchy, swelling at the injection site; Red at the injection site; Drawn out skin reaction and could be cellulitis; left side lymph nodes around the clavicle were inflamed and large; pain at the injection site; A spontaneous report was received from a healthcare professional who was also a 22-years old female patient who received Moderna's COVID-19 (mRNA-1273) developed pain, itching, swelling, redness and discoloration at the injection site, swollen lymph nodes, and possible cellulitis.     The patient's medical history and relevant concomitant medications were not reported.   On 31 Dec 2020, the same day as the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection and experienced injection site pain.  On undisclosed dates over the next week, the patient experienced swollen lymph nodes and itching, swelling, and redness at the injection site. She also experienced shiny skin at the injection site.  On 06 Jan 2021, her lymph nodes became inflamed and she went to Urgent Care, who sent her to the emergency room with symptoms of a possible aneurysm.  She was not admitted to the hospital and on 07 Jan 2021 she returned to Urgent Care where a physician diagnosed possible cellulitis and prescribed antibiotics.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events pain, itching, swelling, redness and discoloration at the injection site, swollen lymph nodes, and possible cellulitis were not reported.; Reporter's Comments: This case concerns a 22-year old, female patient, who is a healthcare professional.  The patient's medical history and relevant concomitant medications were not reported. The patient experienced event of injection site pain, swelling, erythema, pruritis, lymphadenopathy,  injection site skin discoloration and cellulitis. The event started on undisclosed date after receiving the first dose of mRNA-1273 on 31 Dec 2020.The event of lymphadenopathy occurred 7 days after first dose of mRNA-1273. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Between 12-24 hours after receiving the Pfizer covid 19 booster shot, I woke up with a swollen arm pit under my left arm, soreness at the injection site, general soreness in my back, and fatigue. My arm pit is still tender to the touch and sore.
This is a spontaneous report from a contactable medical assistant reporting on behalf of a physician. A 66 year-old Caucasian male patient of an unspecified ethnicity received the first dose of PREVNAR 13, (lot 539564, expiry date Sep2018) intramuscular in the right deltoid on 06Nov2017 at 0.5 ml single for immunization. Medical history included varicose vein diagnosed for a couple of years and unknown if ongoing, the patient was allergic to penicillin. There were no concomitant medications. The patient had previously taken for immunization influenza vaccine in Sep2017, pneumococcal vaccine polysacch 23v on 04Oct2016, diphtheria, TDAP, (lot C5212AA, expiry date 05Jun2019, NDC 49281-400-58P) intramuscular in the left deltoid on 04Aug2017. Since 11Nov2017 the patient's bowel movements and stools have changed from soft to runny and have not changed back. The patient was not recovered from the reported event. The reporter was asking what to do about the event. The patient saw the doctor due to the event on 16Apr2018. The doctor was having the patient's stool tested, no results were available at reporting time. Seriousness of event was not specified.
After the first dose, his arm was sore at the site; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (After the first dose, his arm was sore at the site) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (After the first dose, his arm was sore at the site) (seriousness criterion medically significant). At the time of the report, VACCINATION SITE PAIN (After the first dose, his arm was sore at the site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-249074 (Patient Link).; Sender's Comments: Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Some mild paralysis in the legs that started several hours later in the evening and has continued to this day
Patient stated that he became extremely ill the week following the vaccine. He stated he had constipation, uncontrollable shakes, achiness, nerve pain, fever, and intermittent loss of his sense of taste and smell.
31Jan91 pt vax w/ MMR; 06Feb91 pt inadvertently vax w/ 2nd dose.  No noted problems.
Developed "stinging" sensation on that (L) upper few hrs after vaccination. Got worsened on Saturday with erythema, swelling and large bullae. Seen at ER and here at the office on 8/15/11. On ZITHROMAX, BENADRYL PO and VICODIN prn for pain.
I had gotten off my period in 6/25 and the day after I got the shot I began ANOTHER period for 7 days with HORRIBLE a cramping. I had my tubes tied in June 2020 and have had REGULAR periods since I should now be on by period today 8/23 and I have not had one yet.
so sick that he could not breathe; so sick that he could not breathe; Coma; tested positive for COVID-19; This is a spontaneous report from a contactable consumer (Patient 's son) reported for a patient (Father). This is a report received from a Pfizer-sponsored program. A 72-years-old male patient received first dose of bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0169 and Expiry date: Unknown), via an unspecified route of administration on 29Jun2021 at 17:00 (at the age of 72-yers-old) as DOSE 1, SINGLE for Covid-19 immunisation. The patient medical history included hypertension (Blood pressure high) (Caller says his father has high blood pressure, unknown when diagnosed, and he doesn't remember what medication he took). The patient concomitant medications were not reported (Caller says his father got no other vaccinations the same day as they got the COVID-19 vaccine or recently beforehand, and started no new medications. He says his father has high blood pressure). The patient had experienced so sick that he could not breathe on 04Jul2021 (the reporter says his father on the 3rd and on the 4th was so sick that he could not breathe, so they called the ambulance on 4th and he received treatment in the ICU, which he doesn't know what they did since he cannot see him), coma on Jul2021, tested positive for covid-19 on 02Jul2021. The patient received the first dose of the Pfizer COVID-19 vaccine on June 29th and then two days later he tested positive for COVID-19 and he wants to know if he still gets the second dose of vaccine as well. The patient was hospitalized for so sick that he could not breathe and coma for 18 days. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 27Jun2021, sars-cov-2 test: positive on 02Jul2021 (the reporter says that before they did the shot they did test two things, and on June 27th they were all negative for COVID-19, which was what make us like doesn't know what is going on, since on the 29th they were all positive after vaccine). Therapeutic measures were taken as a result of so sick that he could not breathe. Outcome of the events so sick that he could not breathe, Coma and tested positive for COVID-19 was unknown.  Follow-up attempts are completed. No further information is expected.
Significant soreness at injection site, muscle aches, flu-like symptoms, some nausea, feeling tired.  Symptoms interfered with sleep and were significant in AM.   Got better as day went on.  Was able to go to work (06/20/2019),  but I was wondering if I could when I first woke up.  I expect symptoms to be resolved by  tomorrow or a bit later.
Patient was intended to get age appropriate vaccine, patient was inadvertently given the Pfizer 12 and up, no symptoms at this time.